Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 15/20 | 0.76 |
| ▸ | MAPK14 | Q16539 | 12/20 | 0.76 |
| ▸ | MAPK12 | P53778 | 5/20 | 0.76 |
| ▸ | SRC | P12931 | 10/20 | 0.67 |
| ▸ | SYK | P43405 | 9/20 | 0.67 |
| ▸ | HCK | P08631 | 1/20 | 0.66 |
| ▸ | GSK3B | P49841 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19226086 | 0.95 | MAPK14 (0.77) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19226068 | 0.95 | MAPK14 (0.77) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19750037 | 0.93 | GSK3A (0.78) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19101997 | 0.93 | MAPK14 (0.69) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19102036 | 0.92 | MAPK14 (0.69) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19225942 | 0.92 | MAPK14 (0.78) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19102044 | 0.91 | MAPK14 (0.78) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19226007 | 0.91 | MAPK14 (0.76) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19102027 | 0.91 | SYK (0.82) | GSK3AMAPK14MAPK12SRCSYK | |
| SCHEMBL19226112 | 0.90 | MAPK14 (0.80) | GSK3AMAPK14MAPK12SRCSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9724347-B2 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors | Respivert, Ltd. | 2017-08-08 | — | — | US | disclosed |